A comparison between statin with ACE inhibitor or ARB therapy in STEMI patients who underwent successful PCI with drug-eluting stents - ScienceDirect
Frontiers | Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research
Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19 | Drugs & Therapy Perspectives
COVID-19 and Use of Drugs Targeting the Renin-Angiotensin-System - American College of Cardiology
World's Largest Study on ACE Inhibitors, ARBs Shows No Increased Patient Risk of COVID-19 Diagnosis, Complications - Columbia DBMI
From ACE Inhibitors/ARBs to ARNIs in Coronary Artery Disease and Heart Failure (Part 2/5) | Journal of the American College of Cardiology
RACGP - ACEIs for cardiovascular risk reduction – have we taken our eye off the ball?
Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial - The Lancet Respiratory Medicine
Dual renin-angiotensin system inhibition for prevention of renal and cardiovascular events: do the latest trials challenge existing evidence? | Cardiovascular Diabetology | Full Text
Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients | eLife
Angiotensin-Converting Enzyme Inhibitor vs. Angiotensin Receptor Blockers
ACE Inhibitor and ARB Therapy: Practical Recommendations
Prioritization Tools— ACEI/ARB Case Study - Evaluating the Potential Use of Modeling and Value-of-Information Analysis for Future Research Prioritization Within the Evidence-Based Practice Center Program - NCBI Bookshelf
ACE inhibitors and ARBs: Managing potassium and renal function | Cleveland Clinic Journal of Medicine
Comparative Effectiveness of Sacubitril-Valsartan Versus ACE/ARB Therapy in Heart Failure With Reduced Ejection Fraction - ScienceDirect
Randomized elimination and prolongation of ACE inhibitors and ARBs in coronavirus 2019 (REPLACE COVID) Trial Protocol - Cohen - 2020 - The Journal of Clinical Hypertension - Wiley Online Library
Cross-Reactivity of ACE Inhibitor–Induced Angioedema with ARBs
Monitoring before treatment with ACE inhibitors/ARBs - bpacnz clinical audit
Adding ACE Inhibitors or ARBs to Standard Therapy for Stable Ischemic Heart Disease | AAFP
ARBs in hypertension - The British Journal of Cardiology
Therapeutic impact of the single fixed-dose combination with a high-dose angiotensin-receptor blocker and a low-dose thiazide diuretic in the management of hypertension: awaiting further accumulation of clinical evidence | Hypertension Research
Pathways: ACE Inhibitor Pathway | www.antibodies-online.com
